Introduction
Depression in Parkinson's disease (PD) may affect up to 68.1% of the patients, although prevalence rates may vary among studies due to different evaluation methods, population characteristics and diagnostic criteria used [1, 2] . Despite its high prevalence and the impairment in quality of life [3, 4] , the occurrence of depression in PD is frequently underrecognised, possibly as a result of the lack of specificity of some symptoms that occur in both diseases, such as psychomotor retardation, apathy, concentration disturbances and sleep disorders [5, 6] .
Several scales have been used to detect and quantify depression in PD. The Patient Health Questionnaire-9 (PHQ-9) is a self-rating instrument that uses the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria to evaluate depression. Recently, this instrument has been applied in two studies [7, 8] to detect depression in PD patients. The first study compared different instruments, among which the PHQ-9, but proposed no cut-off score for major depression [8] . The second study compared the accuracy of nine scales for the diagnosis of depressive disorders in PD, and also failed to provide a specific cut-off score for major depression [7] . The lack of a thorough discriminant validity analysis of the PHQ-9 for PD patients hinders the use of the scale in clinical and research settings.
The main objective of the present study, therefore, was to assess the discriminant validity of the PHQ-9 in order to establish the best cut-off score for the diagnosis of major depression in PD patients.
Method Subjects
One hundred and ten consecutive patients followed up at the specialised movement disorders outpatient clinic were assessed with the Structured Clinical Interview for DSM-IV (SCID) [9, 10] . All the subjects invited agreed to participate. Twentyfour (21.8%) patients were unable to understand or to read the self-rating scales and two (1.8%) refused to complete them. Therefore, 84 (76.4%) patients were assessed with the three self-rating scales and included in the validity study.
PD diagnosis was established according to the brain bank criteria of the UK Parkinson's Disease Society [11, 12] . Patients with dementia associated with PD were not included. The presence of dementia was determined by clinical interview with the patient and his caregiver according to DSM-IV.
Self-rating scales

15-item Geriatric Depression Scale (GDS-15)
The GDS-15 was previously validated for the screening of depression in PD [13] , with high accuracy in a sample of Brazilian PD patients [14] .
Zung Self-rating Depression Scale (SDS)
The Brazilian version of the SDS proved adequate for the screening of major depression in PD [15, 16] , with a sensitivity of 88.9%, specificity of 83.3% and area under the receiver operating characteristic curve (AUC) of 0.93 [17] .
PHQ-9
The PHQ-9 consists of nine items based on DSM-IV criteria for major depression and can be used in two forms: (i) as a severity measure or screening tool or (ii) as a diagnostic instrument. As a screening tool, the items are rated on a scale ranging from 0 ('not at all') to 3 ('nearly every day') in respect to the previous 2 weeks, and the total score is based on the sum of the points in each item and ranges from 0 to 27. As a diagnostic instrument, the PHQ-9 indicates the presence of depression when at least five items are scored ≥2, necessarily including anhedonia/apathy or depressed mood (items 1 and 2) [18] . The Brazilian version of the PHQ-9 translated by Pfizer (Copyright© 2005 Pfizer, Inc.) was used after formal authorisation. This Brazilian version has been validated in primary care patients without PD [19] .
Procedures
The study was approved by the local ethics committee (HCRP 12193/2007) and patients signed an informed consent to participate.
After routine neurological consultation, the patients were invited to take part in the study and, after providing formal consent, were examined by a psychiatrist with experience in the administration of the SCID, who also collected clinical and demographic data. Next, the patients were led to a room where they were asked to independently complete the self-rating scales.
Statistical analysis
The comparison between depressed and non-depressed patients was performed using Student's t-test for quantitative variables and the χ 2 test for categorical variables. Spearman's correlation coefficient was used to test the concurrent validity between the PHQ-9 and the GDS-15 and SDS.
The AUC was used as an indicator of the ability of the PHQ-9 to differentiate between patients with and without depression according to the SCID. The cut-off values were determined for the PHQ-9 and their respective sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV) were calculated.
Results
The prevalence of current major depression was 25.5% (n = 28). The socio-demographic and clinical characteristics of the sample are described in Table 1 .
The internal consistency of the PHQ-9 assessed by Cronbach's alpha was 0.83. The AUC was 0.94 and the maximal discrimination between depressed and non-depressed patients was reached for the cut-off of 9 with sensitivity of 100% and specificity of 83.1% (Table 2) .
Considering the PHQ-9 as a diagnostic instrument, the questionnaire had sensitivity of 52.6%, specificity of 95.4%, PPV of 76.9% and NPV of 87.3%. Regarding concurrent validity, the PHQ-9 correlated with the SDS and the GDS-15 with Spearman's coefficient of 0.630 (P < 0.001) for both scales.
Discussion
The PHQ-9 proved adequate for the screening of major depression in PD. The best discrimination between depressed and non-depressed patients was reached with a cut-off score of 9, with a sensitivity of 100% and a specificity of 83.1%, respectively. The first validation study of the PHQ-9 in the general population found the same cut-off score for maximal discrimination, with similar sensitivity and specificity values ranging from 88 to 98% [18, 20] .
The internal consistency observed for the PHQ-9 was similar to that found in other studies for non-parkinsonian populations [21, 22] . The convergent validity was consistent with the correlation coefficients found among validated scales used in this same sample [17, 23] . Also, the other scales used in this study (SDS and GDS-15) had similar psychometric qualities to the PHQ-9 (see Chagas et al. [17] ).
Williams et al. [7] evaluated the validity of the PHQ-9 in PD and compared the psychometric properties of nine scales for depression. In that study, the best cut-off score proposed for the PHQ-9 was ≥6, with a sensitivity of 66%, specificity of 80%, PPV of 69%, NPV of 77% and AUC of 0.81. When estimating the discriminant validity, those authors considered 'active depression' as present in patients with current major depression, minor depression, dysthymia, adjustment disorder with depressed mood and depressive disorder not otherwise specified. The lower cut-off score, sensitivity and predictive values for maximal discrimination between patients with and without depression in the study by Williams et al. [7] can probably be explained by the inclusion of depressive disorders other than major depression. In support to this, Spitzer et al. [20] , for example, found a sensitivity of 73% for the detection of major depressive disorder, but of 61% for any mood disorder.
When the PHQ-9 diagnostic algorithm was applied, we found a sensitivity of 52.6% and a specificity of 95.4%. This result is compatible with a study that evaluated patients with chronic clinical disorders and found sensitivity values between 34.9 and 50.5% [24] . Recently, Thompson et al. [8] assessed the validity of three instruments (PHQ-9, GDS-15, SCID) for the diagnosis of depression in PD. According to their findings, the PHQ-9 algorithm for the diagnosis of depression had a sensitivity of 54% and a specificity of 85% for the diagnosis of any depressive disorder relative to the SCID. This result is similar to what we found when the same diagnostic algorithm was used, which suggests that this algorithm may not be an effective way to identify major depression in PD. The disagreement between self-reporting scales and clinical interviews has been discussed by Thompson et al. [8] and may be related to the overlapping of depression and PD symptoms, which can be differentially rated by patients and clinical interviewers. As a result, the NINDS/NIMH work group recommended that items such as altered concentration, apathy and psychomotor retardation be excluded from the screening of depression in PD [25] .
One limitation of our study is the fact that a high proportion (21.8%) of patients who underwent the psychiatric assessment were unable to understand or read the self-rating scales due to their low educational level. It should be taken into account, therefore, that although the PHQ-9 is an useful instrument for the screening of depression in PD, its use seems to be influenced by the education of the population assessed. 
Conclusion
The diagnostic algorithm of the PHQ-9 does not seem to be an effective strategy to identify major depression in PD, although the questionnaire is valid for the screening of major depression in this population. According to our findings, the best cut-off point for this sample is 9, with a sensitivity of 100% and specificity of 83.1%. Low education can be an important limitation for the use of self-reporting scales and its real impact should be the object of future research.
Key points
• The diagnostic algorithm of the PHQ-9 does not seem to be an effective strategy to identify major depression in PD.
• The best cut-off point of PHQ-9 is 9 for major depression in PD, with a sensitivity of 100% and specificity of 83.1%.
• The PHQ-9 is an adequate instrument for the screening of major depression in PD.
Conflicts of interest
None declared. 
